Open Journal of Epidemiology

Volume 11, Issue 3 (August 2021)

ISSN Print: 2165-7459   ISSN Online: 2165-7467

Google-based Impact Factor: 0.53  Citations  

Lipid Accumulation Product: Reliable Marker for Cardiovascular Risk Detection?

HTML  XML Download Download as PDF (Size: 1899KB)  PP. 267-277  
DOI: 10.4236/ojepi.2021.113023    167 Downloads   1,008 Views  Citations

ABSTRACT

The Lipid Accumulation Product (LAP) is a clinical marker of visceral obesity and has been proposed as a simple, inexpensive, and accurate tool to estimate cardiovascular risk and mortality. The aim of this study was to verify the association of LAP with anthropometric, biochemical, visceral adiposity index and IR in adults and the elderly. This single cross-section center clinical study, with experimental, analytical, primary, and observational design, included 210 participants. Anthropometric (Body Mass Index (BMI), Waist Circumference (WC), and Neck Circumference (NC)), LAP, Visceral Adipose Index (VAI), and biochemical parameters (fasting glycemia, insulinemia (to calculate the Homa-IR index), total cholesterol, LDL-c, HDL-c, and triglycerides) were evaluated. The results showed that by separating the sample into three groups (adequate BMI and WC, adequate BMI and elevated WC, and elevated BMI and WC), the group with high BMI and WC showed a high value of LAP and VAI compared to the other groups, with a significant difference. Still, the data show a positive and significant correlation when relating the LAP with VAI, HOMA-IR, BMI, WC, NC, total cholesterol, triglycerides, and Diastolic Blood Pressure. It also showed an inversely proportional relationship when associating LAP with HDL-c (p < 0.0001). Thus, we show that LAP is closely related to visceral adiposity, IR, altered lipid parameters, and blood pressure, especially diastolic in the patients included in our study. For these reasons, we suggest that LAP is a reliable indicator of promising visceral adiposity for early detection of cardiovascular risk in the adult and senior population.

Share and Cite:

Pires, L. , Tofano, R. , Barbalho, S. , Detregiachi, C. , Bechara, M. , Tofano, V. , Haber, J. , Chagas, E. , Milla, A. and Quesada, K. (2021) Lipid Accumulation Product: Reliable Marker for Cardiovascular Risk Detection?. Open Journal of Epidemiology, 11, 267-277. doi: 10.4236/ojepi.2021.113023.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.